[Elsevier] [Supplementary]Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study |
|
This post will be closed automatically in 2026-07-02 22:22
Reward10points
|
| |
10
Hierarchically porous SiOx/C and carbon materials from one biomass waste precursor toward high-performance lithium/sodium storage
10
Understanding the impact of the built environment mosaic on rainfall-runoff behaviour
10
Ethical, legal, and regulatory perspectives in computational drug design
30
Drug Coated Balloon-based angioplasty for Chronic Total Occlusions: The PICCOLETO X study
10
Pulp and paper industry wastewaters and pollutants: characteristics, recovery, and utilization
